Transamerica Financial Advisors, LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1502149 CEDAR RAPIDS, IA

Position in REGN

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$53,312

+$16,263 QoQ

Shares Held

+43.8% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2021

10 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Mar 31, 2026

Transamerica Financial Advisors, LLC holds $4,417,425 across 49 Biotechnology names. REGN ranks #8 (1.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	9,303	$3,078,083
2	VRTX	Vertex Pharmaceuticals Inc / Ma	941	$420,194
3	RPRX	Royalty Pharma plc	6,094	$292,329
4	EXEL	Exelixis, Inc.	3,297	$141,408
5	INSM	INSMED Inc	758	$123,948
6	ARGX	Argenx SE	137	$100,044
7	ACAD	Acadia Pharmaceuticals Inc	3,544	$78,889
8	REGN	Regeneron Pharmaceuticals, Inc. This page	69	$53,312

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$53,312	69	+43.8%	Shares	Sole	2026-05-15
2025-12-31	$37,049	48	+380.0%	Shares	Sole	2026-02-13
2025-09-30	$5,622	10	+233.3%	Shares	Sole	2025-11-14
2023-09-30	$2,468	3	-25.0%	Shares	Sole	2023-11-14
2023-06-30	$2,874	4	0.0%	Shares	Sole	2023-08-14
2023-03-31	$3,286	4	0.0%	Shares	Sole	2023-05-15
2022-12-31	$2,885	4	-20.0%	Shares	Sole	2023-02-14
2022-09-30	$3,444	5	0.0%	Shares	Sole	2022-11-14
2022-06-30	$2,955	5	+400.0%	Shares	Sole	2022-08-15
2021-06-30	$558	1	—	Shares	Sole	2021-08-10
No filing history on record for this holder in this stock.